Convergence Investment Partners, LLC Myriad Genetics Inc Transaction History

Convergence Investment Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$27.23 - $45.56 $307,317 - $514,190	-11,286 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$37.57 - $50.34 $1.06 Million - $1.42 Million	-28,177 Reduced 71.4%	11,286 $519,000
Q2 2018 Aug 07, 2018	SELL	$27.75 - $40.17 $2.34 Million - $3.38 Million	-84,264 Reduced 68.1%	39,463 $1.48 Million
Q1 2018 May 14, 2018	BUY	$28.83 - $41.01 $387,763 - $551,584	13,450 Added 12.2%	123,727 $3.66 Million
Q4 2017 Jan 16, 2018	BUY	$28.45 - $37.14 $3.14 Million - $4.1 Million	110,277	110,277 $3.79 Million

238

92.7M

117K

113K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.77B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Convergence Investment Partners, LLC with notifications on news.